Tremfya 100 mg/1 ml
Tremfya 100 mg/1 ml is a medicine authorised by Swissmedic under authorisation number 66583. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 June 2018 and the authorisation is valid without a time limit. ATC code L04AC16 places the medicine in the group Immunosuppressants.
| Authorisation number | 66583 |
|---|---|
| Name | Tremfya 100 mg/1 ml |
| Full name | Tremfya 100 mg/1 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC16 |
| First authorisation | 13 June 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tremfya 100 mg/1 ml, Injektionslösung in einer Fertigspritze | B | 13 June 2018 |
| 2 | Tremfya 200 mg/2 ml, Injektionslösung in einer Fertigspritze | B | 10 June 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | L04AC16 | 07.15.0. | B |
| 2 | 1 | Fertigspritze(n) | L04AC16 | 07.15.0. | B |
| 3 | 2 | Fertigspritze(n) | L04AC16 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tremfya 100 mg/1 ml authorised in Switzerland?
Yes. Tremfya 100 mg/1 ml is authorised by Swissmedic under authorisation number 66583, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tremfya 100 mg/1 ml have?
Tremfya 100 mg/1 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Tremfya 100 mg/1 ml?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.